MedPath

Cefoxitin

Cefoxitin for Injection, USP

Approved
Approval ID

f5288962-caee-4771-8229-df9cdefcfa67

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 16, 2023

Manufacturers
FDA

WG Critical Care, LLC

DUNS: 829274633

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefoxitin

PRODUCT DETAILS

NDC Product Code44567-247
Application NumberANDA065415
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateOctober 16, 2023
Generic NameCefoxitin

INGREDIENTS (2)

CEFOXITIN SODIUMActive
Quantity: 10 g in 1 1
Code: Q68050H03T
Classification: ACTIM
NATURAL LATEX RUBBERInactive
Quantity: 0 1 in 1 1
Code: 2LQ0UUW8IN
Classification: CNTM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefoxitin - FDA Drug Approval Details